Intrathecal glycine for pain and dystonia in complex regional pain syndrome.

@article{Munts2009IntrathecalGF,
  title={Intrathecal glycine for pain and dystonia in complex regional pain syndrome.},
  author={Alexander G. Munts and Anton Adriaan van der Plas and Joan H C Voormolen and Johan Marinus and Irene M. Teepe-Twiss and Willem Onkenhout and Joop M van Gerven and Jacobus Johannes van Hilten},
  journal={Pain},
  year={2009},
  volume={146 1-2},
  pages={199-204}
}

• Alexander G. Munts, Anton Adriaan van der Plas, +5 authors Jacobus Johannes van Hilten
• Published 2009 in Pain
• DOI:10.1016/j.pain.2009.07.030

Since glycinergic neurotransmission plays an important inhibitory role in the processing of sensory and motor information, intrathecal glycine (ITG) administration may be a potential therapy for both pain and movement disorders in patients with complex regional pain syndrome (CRPS). Aims of the current study, which is the first report on ITG in humans, were… CONTINUE READING

Save

Watch Paper

Cite

View on PubMed